多家上市公司业绩预告“变脸”，星光股份等收到警示函

Core Viewpoint - The article highlights the trend of listed companies in China revising their earnings forecasts for 2024, with many experiencing significant changes in their financial outlook, leading to stock price volatility and potential legal repercussions for misleading disclosures [1][2][3]. Group 1: Earnings Forecast Revisions - Jinkang Photovoltaic revised its 2024 revenue forecast from an expected range of CNY 110 million to CNY 150 million down to CNY 67.301 million [1] - Numerous A-share listed companies have issued earnings forecast revisions from January to April 2024, with some transitioning from profit to loss, including Huaxi Energy, Xingguang Co., and Sailong Pharmaceutical [1] - The revisions have led to substantial stock price fluctuations, resulting in losses for investors [1] Group 2: Regulatory Actions - Xingguang Co. received a warning letter from the Guangdong Securities Regulatory Bureau for significant discrepancies between its earnings forecast and actual results, failing to disclose potential delisting risks in a timely manner [2] - The company initially forecasted profits in its January 20 announcement but later revised it to expected losses in April [2] - Huijin Technology also received a warning letter for not disclosing revenue figures and potential delisting risks in its earnings forecast, which indicated a loss of CNY 14.5 million to CNY 19.8 million [3]